ReOrganic Womans Inner Care Essence Gel

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: ReOrganic Womans Inner Care Essence Gel
Generic name: ADENOSINE
Manufacturer: LAON COMMERCE co ltd
Product type: HUMAN OTC DRUG
SPL set ID: fc7ec752-c676-93b8-e053-6294a90a4402
SPL ID: fc7eaa91-3479-d03e-e053-6394a90a2248
Version: 1
Effective date: 2023-05-25
Source export date: 2026-10-27
Source partition: 7
Source file: https://download.open.fda.gov/drug/label/drug-label-0007-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-27/be847f9aea8d80a2cb7e9771acd1143be084664192ecf8f5be8ac1024116f4f0/drug-label-0007-of-0014.json.zip
Source manifest SHA-256: 6be3667a3beefe6c0ead4c723ea963050533a2bc725a8044d58b07d18b258c55
Import run: 20261027T193451Z
Imported at: 2026-10-27 20:12:03

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 9 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
brand name		ReOrganic Womans Inner Care Essence Gel	openfda.brand_name
generic name		ADENOSINE	openfda.generic_name
manufacturer name		LAON COMMERCE co ltd	openfda.manufacturer_name
ndc	package	82083-0018-1	openfda.package_ndc
ndc	product	82083-0018	openfda.product_ndc
ndc11	package	82083001801	derived:openfda.package_ndc
spl id		fc7eaa91-3479-d03e-e053-6394a90a2248	id
spl set id		fc7ec752-c676-93b8-e053-6294a90a4402	set_id
unii		K72T3FS567	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

1. When using cosmetics or after use, consult with a sp ecialist if there are any abnormal symptoms or side effects such as red spots, swelli ng, or itching in the area of use due to direct sunlight. 3. Precautions for storage and handling A) Keep out of reach of children B) Keep away from direct sunlight

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.